The kit is used at a clinic after the patient receives instructions from a healthcare worker, and the swab is then sent for laboratory testing using Roche’s cobas HPV test. It offers an ...

The cobas liat test aims to improve patient outcomes by offering rapid, accurate results in decentralized and community-based settings for patients at risk for chlamydia, gonorrhea, and Mycoplasma ...

The US Food and Drug Administration (FDA) has approved Roche’s cobas epidermal growth factor receptor (EGFR) Mutation Test v2. The decision makes it the first FDA-approved, blood-based genetic ...

Roche (OTCQX:RHHBY ... The drugmaker confirmed that its cobas MPXV test, as well as the LightMix research use only kits, detect the latest mpox virus variants.

In November 2022, Roche received emergency use authorisation from the FDA for its mpox virus detection test, cobas MPXV, for use on the cobas 6800/8800 Systems. "Roche’s cobas 6800/8800 systems ...

Metropolis Healthcare and Roche Diagnostics India introduce self-sampling HPV DNA test for cervical cancer screening at home.

"The HPV test will be rolled out on February 4 to coincide with World Cancer Day," an official with Metropolis said ...

Basel, 13 December 2024 - Roche ... cobas® 6800/8800 systems 2.0. The update significantly enhances the efficiency of laboratories by optimising resources, reducing downtime, consolidating test ...